Press Releases and Events

NEWS:

December, 2021: „Hearing loss company Acousia Therapeutics to receive CTA for first-in-man clinical study of ACOU085“

BfArM CTA approval ACOU085

May, 2021: „Hearing Loss Company Acousia Therapeutics Presenting at Upcoming Drug Development and B2B Conferences“

https://www.b3cnewswire.com/202105102218/hearing-loss-company-acousia-therapeutics-presenting-at-upcoming-drug-development-and-b2b-conferences.html

November, 2020: „Hearing Loss Company Acousia Therapeutics Strengthening its R&D Management Team“

https://www.b3cnewswire.com/202011022142/hearing-loss-company-acousia-therapeutics-strengthening-its-r-d-management-team.html

May, 2018: „Acousia Therapeutics Announces €10 Million Series B Financing to Advance its Hearing Loss Portfolio“

Acousia Financing Round 2018

December, 2016: „Acousia Therapeutics Receives EUR 2.5 Million to Develop Innovative Therapy to Treat and Prevent Sensorineural Hearing Loss“

Acousia Financing Round 2016


EVENTS:

May 17-18, 2022: Acousia will be presenting at BIOEQUITY in Milan, Italy

BioCentury